Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
NMR Research Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
J Neurol. 2024 Aug;271(8):5074-5082. doi: 10.1007/s00415-024-12448-4. Epub 2024 May 28.
We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA) to confirmed disability accrual (CDA) and transition to secondary progression (SP) in relapsing multiple sclerosis (MS).
Relapsing-onset MS patients with follow-up > / = 5 years (16,130) were extracted from the Italian MS Registry. CDA was a 6-month confirmed increase in Expanded Disability Status Scale (EDSS) score. Sustained disability accumulation (SDA) was a CDA with no EDSS improvement in all subsequent visits. Predictors of PIRA and RAW and the association between final EDSS score and type of CDA were assessed using logistic multivariable regression and multivariable ordinal regression models, respectively.
Over 11.8 ± 5.4 years, 16,731 CDA events occurred in 8998 (55.8%) patients. PIRA (12,175) accounted for 72.3% of CDA. SDA occurred in 8912 (73.2%) PIRA and 2583 (56.7%) RAW (p < 0.001). 4453 (27.6%) patients transitioned to SPMS, 4010 (73.2%) out of 5476 patients with sustained PIRA and 443 (24.8%) out of 1790 patients with non-sustained PIRA. In the multivariable ordinal regression analysis, higher final EDSS score was associated with PIRA (estimated coefficient 0.349, 95% CI 0.120-0.577, p = 0.003).
In this real-world relapsing-onset MS cohort, PIRA was the main driver of disability accumulation and was associated with higher disability in the long term. Sustained PIRA was linked to transition to SP and could represent a more accurate PIRA definition and a criterion to mark the putative onset of the progressive phase.
我们旨在研究复发相关恶化(RAW)和与复发无关的进展(PIRA)的发生及其对确诊残疾进展(CDA)和继发进展(SP)的相对贡献,以评估复发型多发性硬化症(MS)患者的病情进展。
从意大利 MS 注册中心提取了随访时间≥5 年(16,130)的复发型 MS 患者。CDA 定义为扩展残疾状况量表(EDSS)评分在 6 个月内确认增加。持续性残疾累积(SDA)是指 CDA,且在所有后续就诊中 EDSS 无改善。采用多变量逻辑回归和多变量有序回归模型评估 PIRA 和 RAW 的预测因素以及最终 EDSS 评分与 CDA 类型之间的关联。
在 11.8±5.4 年期间,8998 名患者(55.8%)发生了 16731 次 CDA 事件。PIRA(12175 次)占 CDA 的 72.3%。SDA 发生在 8912 次 PIRA(73.2%)和 2583 次 RAW(56.7%)中(p<0.001)。4453 名(27.6%)患者进展为继发进展型 MS,4010 名(73.2%)持续 PIRA 患者和 1790 名(24.8%)非持续 PIRA 患者进展为继发进展型 MS。在多变量有序回归分析中,更高的最终 EDSS 评分与 PIRA 相关(估计系数 0.349,95%CI 0.120-0.577,p=0.003)。
在这个现实世界的复发型 MS 队列中,PIRA 是残疾累积的主要驱动因素,与长期更高的残疾相关。持续的 PIRA 与继发进展相关,可能代表了更准确的 PIRA 定义和标志进展阶段开始的标准。